ADIPOQ and obesity due to melanocortin 4 receptor deficiency: While a number of experimental studies have established a key role for adiponectin as an anti-inflammatory agent in relation to obesity and cardiovascular disease, in part through inhibition of inflammatory cytokines [3–5], its role in inflammatory pain is largely unknown.